In what can only be described as a transformative turning point for India’s medical technology sector, India Health 2025, hosted by Informa Markets at Pragati Maidan, New Delhi, has emerged as more than just a healthcare exhibition — it is a testament to India's medtech
The second edition of the India Health Exhibition 2025, organised by Informa Markets in India, was inaugurated today at Bharat Mandapam, New Delhi, highlighting the rising demand and immense potential in this sector. The three-day event, which concludes on 13th July 2025, returns with renewed
The Association of Indian Medical Device Industry (AiMeD) praised the Government of India for progressive reforms in public procurement and the robust judicial support that ensures the reiteration of the country's commitment to Atmanirbharta in healthcare which became a national imperative post Covid . With
Rajiv Nath, Forum Coordinator of AiMeD on UK-India Free Trade Agreement (FTA).While this a path breaking initiative, FTAs in past have been detrimental to medical devices sector and only made us more important dependent and less Atmaribhar - we had explained our concerns to Department
In a significant policy development, the Government of Gujarat has reversed its earlier decision to exempt stents from the purview of central pricing regulation under the Clinical Establishments Act. This comes after broad-based feedback and concern from industry stakeholders, patient advocacy groups, and healthcare experts.Simultaneously,
In a move that has sent shockwaves through the Indian medical device industry, former U.S. President Donald Trump has imposed a 26% reciprocal tariff on medical device exports from India. This decision, aimed at correcting perceived trade imbalances and promoting domestic manufacturing in the U.S.,
The Association of Indian Medical Device Industry (AiMeD) has raised strong objections to a recent notification issued on March 10, 2025, by the Commissionerate of Health, Medical Services & Medical Education, Government of Gujarat. The notification sets an unjust reimbursement structure, allocating ₹25,000 for USFDA-approved
Calls for Policy Reforms to Curb Unfair Import Practices and Boost Make-in-India Initiative in Medical Devices SectorThe Association of Indian Medical Device Industry (AiMeD), representing domestic manufacturers, has called upon the government to impose safeguard duties on imported medical devices to protect India’s burgeoning medical
The Association of Indian Medical Device Industry (AiMeD) today emphasized the need for the Indian government to revisit tariff structures considering the ongoing efforts to enhance healthcare security in India and address potential challenges arising from global health crises.In a statement, AiMeD expressed concern over
In the pursuit of accessible and cost-effective healthcare, refurbished medical devices have emerged as a pivotal component in India's medical infrastructure. By providing high-quality equipment at reduced costs, these devices are instrumental in bridging the healthcare gap, particularly in underserved regions.The Role of Refurbished Medical
